Quentis Therapeutics

BiotechnologySeries ANew York, USquentistx.com

Latest round

Series A

Last raised

Feb 2018

Total raised

$48M

Investors

7

About Quentis Therapeutics

Quentis Therapeutics, Inc. is a biotechnology company focused on developing innovative therapies for cancer treatment.Founded in 2016, Quentis Therapeutics, Inc. is headquartered in New York, US and specializes in cancer therapeutics.The company offers a range of innovative cancer therapies designed to meet specific medical needs, focusing primarily on targeted treatments. These products aim to enhance treatment efficacy and improve patient outcomes in oncology. Quentis Therapeutics serves a diverse client base that includes healthcare providers, research institutions, and pharmaceutical companies across North America and Europe.Quentis Therapeutics generates revenue through a combination of strategic partnerships and direct contracts with healthcare providers, which include both research collaborations and clinical trial agreements. Their pricing strategy is designed to accommodate various healthcare systems, ensuring accessibility while supporting ongoing research and development efforts. The company also aims to expand its market presence in Europe and Asia by 2024, building on its existing partnerships to support this geographic expansion.

Who invested in Quentis Therapeutics

7 investors across 1 round

See all investors in Quentis Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Feb 27, 2018

    Amount

    $48M

    Investors

    Locked

Questions about Quentis Therapeutics

Who invested in Quentis Therapeutics?

Quentis Therapeutics has 7 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Quentis Therapeutics raised?

Quentis Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Quentis Therapeutics last raise money?

Quentis Therapeutics's most recent round on record is a Series A, in Feb 2018.

What does Quentis Therapeutics do?

Quentis Therapeutics is a biotechnology company.

Where is Quentis Therapeutics headquartered?

Quentis Therapeutics is headquartered in New York, US.

Which VCs invest in companies like Quentis Therapeutics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Quentis Therapeutics's stage. Their profiles are linked below.

Raising like Quentis Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.